CONMED Corporation vs. Iridex Corp
CONMED Corporation (CNMD) comes out ahead, leading on 2 of 3 compared factors.
Size & Scale
| CNMD | IRIX | |
|---|---|---|
| Market Cap | $1.53 billion | $13.16 million |
| Revenue (TTM) | $1.37 billion | — |
| Net Income (TTM) | $56.50 million | — |
CNMD leads on 1 of 1 size & scale factors.
Valuation
| CNMD | IRIX | |
|---|---|---|
| P/E Ratio | 27.61 | — |
| Price / Book | 1.47 | 3.62 |
| Price / Sales | 1.12 | — |
CNMD leads on 1 of 1 valuation factors.
Profitability
| CNMD | IRIX | |
|---|---|---|
| Net Margin | 4.12% | — |
| Return on Equity | 5.43% | — |
CNMD and IRIX split the profitability factors evenly.
Dividend
| CNMD | IRIX | |
|---|---|---|
| Dividend Yield | 1.57% | — |
| Payout Ratio | 43.24 | — |
CNMD and IRIX split the dividend factors evenly.
Risk & Sentiment
| CNMD | IRIX | |
|---|---|---|
| Short Interest | 2.50% | 1.24% |
IRIX leads on 1 of 1 risk & sentiment factors.
Dig deeper: CNMD overview, CNMD financials, IRIX overview, IRIX financials.
Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.